Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5713640 | American Journal of Otolaryngology | 2017 | 4 Pages |
Abstract
Angiosarcoma of the tongue is a rare and highly aggressive tumor, accounting for fewer than 1% of all head and neck malignancies. The mainstay of treatment is surgical resection with negative margins followed by adjuvant chemoradiation for high-risk features. Due to rarity of the disease, consensus on optimal treatment approach is lacking, and multi-center prospective studies would be helpful to set clinical guidelines.
Related Topics
Health Sciences
Medicine and Dentistry
Otorhinolaryngology and Facial Plastic Surgery
Authors
Pratik B. Patel, Edward C. Kuan, Kevin A. Peng, Frederick Yoo, Scott D. Nelson, Elliot Abemayor,